Daily Bulletin

Men's Weekly

.

QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
  • STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary Medicine for the treatment of non-metastatic mast cell tumours (MCT) in dogs, making it the first pharmaceutical treatment available for all grades of canine non-metastatic MCT[1]
  • FDA approval follows the early 2020 marketing...

Read more: QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours-PR Newswire APAC

Business News

Online Site Inductions for Busy HR Teams

Induct For Work, the Australian platform for frontline onboarding and compliance, has launched Compliance Hub, a fully integrated, real-time workflow designed specifically for the fast-paced, highly m...

Daily Bulletin - avatar Daily Bulletin

Reporting Tools in Cybersecurity and Penetration Testing

Reporting is a critical part of every penetration testing engagement. After vulnerabilities have been identified and verified, the findings must be documented clearly and systematically to inform deve...

Daily Bulletin - avatar Daily Bulletin

High-Quality Stainless Steel Suppliers in Melbourne | Stainless Trading Melbourne

Stainless steel plays a crucial role in modern industries due to its exceptional durability, outstanding corrosion resistance, and aesthetically pleasing appearance. It is used in many applications...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals